(Q35218703)

7 August 2017

1 reference

title

Angiogenic protein therapy (English)

1 reference

7 August 2017

Marc Ruel

1

1 reference

7 August 2017

Frank W Sellke

series ordinal

2

1 reference

7 August 2017

publication date

1 July 2003

1 reference

Seminars in thoracic and cardiovascular surgery

7 August 2017

published in

1 reference

7 August 2017

volume

15

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

222-235

1 reference

Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplant patients with graft coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Coronary artery bypass grafting after orthotopic heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

First myocardial infarction in patients of Indian subcontinent and European origin: comparison of risk factors, management, and long term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Atheromatous plaque reflects serum total cholesterol levels: a comparative morphologic study of endarterectomy coronary atherosclerotic plaques removed from patients from the southern part of India and Caucasians from Ottawa, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Importance of complete revascularization in performance of the coronary bypass operation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Direct myocardial revascularization and angiogenesis--how many patients might be eligible?

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Isolated bypass grafting of the left internal thoracic artery to the left anterior descending coronary artery: late consequences of incomplete revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Mechanisms of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Molecular mechanisms of blood vessel growth

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Fibroblast growth factor-1 stimulates branching and survival of myocardial arteries: a goal for therapeutic angiogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Molecular basis of angiogenesis. Role of VEGF and VE-cadherin.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Angiographic methods to assess human coronary angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Effects of antecedent anginal episodes and coronary artery stenosis on left ventricular function during coronary occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Elevation of Vascular Endothelial Growth Factor-A Serum Levels Following Acute Myocardial Infarction. Evidence for its Origin and Functional Significance

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Expression of vascular endothelial growth factor in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Expression of vascular endothelial growth factor and its receptors is increased, but microvascular relaxation is impaired in patients after acute myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Early expression of angiogenesis factors in acute myocardial ischemia and infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Effects of the repeated administration of adenosine and heparin on myocardial perfusion in patients with chronic stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Bumetanide and furosemide inhibited vascular endothelial cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

New activity of spironolactone. Inhibition of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

COX-2 inhibitors. A new class of antiangiogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Controlled and modulated release of basic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Changes in coronary flow following repeated brief coronary occlusion in the conscious dog

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

A new animal model of controlled coronary artery occlusion in conscious rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Coronary collateral development in swine after coronary artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

VEGF administration in chronic myocardial ischemia in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Molecular mechanisms of coronary collateral vessel growth

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

A model to assess interventions to improve collateral blood flow: continuous administration of agents into the left coronary artery in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Angiogenesis in ischemic human myocardium: clinical results after 3 years

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

VEGF gene therapy: stimulating angiogenesis or angioma-genesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Correction of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Changes in glomerular epithelial cells induced by FGF2 and FGF2 neutralizing antibody in puromycin aminonucleoside nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

In vivo angiogenesis in normal and portal hypertensive rats: role of basic fibroblast growth factor and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Role of endothelial nitric oxide synthase in endothelial cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

Role of nitric oxide in the angiogenesis of avascular tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1043-0679%2803%2970002-1

7 January 2021

10.1016/S1043-0679(03)70002-1

Identifiers

DOI

1 reference

release_5bvycitckndlvb6gsyjrt7d3pi

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5bvycitckndlvb6gsyjrt7d3pi

24 November 2022

mapped directly with Wikidata item

1 reference